Navigation Links
Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
Date:4/8/2009

BALTIMORE, April 8 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established a UK subsidiary, Champions Biotechnology UK Ltd. (CBUK), to expand its personalized oncology business. Guy Malchi has been appointed General Manager of the UK subsidiary, which will also have a branch in Israel.

"We have been experiencing an increase in activity in all of our business, particularly in our personalized oncology service. Significantly, much of the increased activity in our personalized oncology business is from leading oncologists in Europe as they recognize the enhancement to their practice that is available by utilizing Champions' services. Champions Biotechnology UK Ltd. will enable our services to be accessible to many more physicians in Europe and beyond. The growing trend of medical tourism in Israel has prompted us to establish a branch in Israel to offer our services there as well," said Doug Burkett, PhD, President of Champions Biotechnology, Inc.

Dr. Burkett continued, "I am delighted to welcome Guy Malchi on board as he transitions from consultant to take on the leadership role for CBUK. He will also lead our corporate development efforts, which are focused on in-licensing and co-development of oncology drug candidates that have proven successful in our Biomerk Tumorgraft(TM) platform. Guy's expertise in strategy implementation and business development are a valuable benefit to Champions."

"I am thrilled to join Champions Biotechnology to help it realize its high potential," said Mr. Malchi. "I was drawn to the unique interaction between personalized medicine and drug development, and I look forward to contributing to the firm's success."

Guy Malchi, MBA brings more than twelve years
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
2. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
3. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
4. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
6. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
7. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
8. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
9. Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million
10. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
11. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... from TU Delft and VU University Amsterdam in the Netherlands ... influences the speed with which hydrogen gas is released when ... the nanoparticle, the greater the speed at which the hydrogen ... publish their findings in the October issue of the scientific ...
... Children,s Oncology Group (COG) and APEIRON ... investigate Apeiron,s APN301 in a clinical phase II study ... (Apeiron) and the Children,s Oncology Group (COG) today announced ... in neuroblastoma patients. Neuroblastoma, a cancer of the nervous ...
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), today ... accepted for poster presentations and an oral presentation at ... Society. This meeting will be held October 1-5, 2011 ... Details on the presentation times are ...
Cached Biology Technology:Hydrogen released to fuel cell more quickly when stored in metal nanoparticles 2Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 2Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 3Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 4Orexigen® Therapeutics Announces Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society 2
(Date:4/15/2014)... high sea levels will rise into the next century, ... University scientist Rene Price. , Price is also affiliated ... Long-Term Ecological Research (LTER) site, one of 25 such ... deserts, mountains to salt marshes around the world. , ... the most certain consequences of climate change. , But ...
(Date:4/15/2014)... University of Missouri researchers have previously shown that ... to exercise exists. In a new study, Frank Booth, ... has found a potential link between the genetic pre-disposition ... at which mental maturation occurs. , For his study, ... extreme activity or extreme laziness. Booth then put the ...
(Date:4/15/2014)... the deadliest infectious diseases recognized the contributions of Frederick ... University of Texas Medical Branch, with a Lifetime Achievement ... The filoviruses include Ebola and Marburg viruses that cause ... The current outbreak of Ebola virus raging in West ... , "This award represents the culmination of a ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2Genetic pre-disposition toward exercise and mental development may be linked 2International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3
... $7.5 million grant to a multi-university consortium led by the ... insects and bats in order to develop aerial vehicles that ... such as zooming through dense forests or landing on moving ... or in very controlled environments," said principal investigator Kristi Morgansen, ...
... This release is available in Spanish . ... Athens, Georgia, have reported for the first time that ... aspergilli, are capable of infecting corn and peanuts as ... these species produced mycotoxins. Using a molecular procedure ...
... (BRONX, NY) The National Institute of General ... of Medicine of Yeshiva University a five-year, $30 ... thousands of biomedically important proteins. "Determining the structures ... role in normal biological processes as well as in ...
Cached Biology News:UW leading $7.5 million study of animal flight and aerial vehicles 2Black aspergilli species responsible for infecting corn identified 2Einstein receives $30 million to study protein form and function 2Einstein receives $30 million to study protein form and function 3Einstein receives $30 million to study protein form and function 4
... Gene expression profiling allows a high-throuput screening ... naturally occuring or artifitially induced changes in ... that system can be detected, studied, classified ... broad range of genes at a glance. ...
... SYBR Green II RNA gel stain ... stain that has bright fluorescence when bound ... making it ideal for use with either ... or standard UV transilluminators. A 500 µL ...
Rabbit polyclonal to Esa1 ( Abpromise for all tested applications)....
... RNA gel stain is a sensitive nucleic ... bound to RNA and low background in gels, ... or polyacrylamide gels using laser scanners or standard ... 500 µL unit size (S-7564) and a special ...
Biology Products: